Medication
Buprenorphine-Naloxone (Suboxone)
Suboxone is a medicine that used to treat opioid addiction in adults and is successful when used in conjunction with a treatment program that also includes counseling and behavioral therapy.
Sublocade Injection
SUBLOCADE is a prescription drug that’s used to treat adults who are addicted to opioid drugs (like prescription painkillers or illegal drugs). It’s injected under the skin in the abdominal area once a month.
Vivitrol Injection
Vivitrol is a medicine used to help people who are dependent on alcohol or opioids. It is given as a shot once a month and contains a chemical called naltrexone which blocks the effects of opioids in the brain. When it comes to alcohol dependence, Vivitrol is believed to make it easier to resist drinking.
Talk with a provider to find what's best for you!
It’s important to remember that healthcare providers are there to assist and support you in finding the best treatment options. They can provide medical expertise, personalized care, and ongoing support to help you manage your condition effectively. Open communication with your healthcare provider allows for collaborative decision-making and ensures that you receive the most appropriate and effective medication for your specific needs.
Healthcare providers have the knowledge and expertise to assess your specific needs and make informed decisions regarding medication. They are trained to evaluate your medical history, symptoms, and any potential contraindications or interactions with other medications you may be taking. They can provide accurate information about available medications, the benefits, potential side effects, and the appropriate dosage.
Why is Medically assisted treatment effective?
Medically assisted drug treatment, which combines medications such as methadone, buprenorphine, or naltrexone with counseling and behavioral therapies, has been shown to be effective in opioid addiction treatment. Here are several reasons why medically assisted drug treatment is effective:
Relieves Withdrawal Symptoms
Medications used in medically assisted treatment, such as methadone and buprenorphine, can help alleviate withdrawal symptoms that occur when individuals stop using opioids. By providing a stable dose of medication, these medications prevent or minimize the discomfort associated with withdrawal, making it easier for individuals to initiate and maintain treatment.
Normalizes Brain Function
Opioid addiction affects the brain's reward and pleasure systems, leading to imbalances and dysregulation. Medications used in medically assisted treatment, such as methadone and buprenorphine, can help restore balance and normalize brain function by occupying opioid receptors and providing a controlled dose of opioids. This can improve cognitive function, emotional stability, and overall well-being.
Reduces Cravings
Medications used in opioid addiction treatment, particularly buprenorphine and methadone, can help reduce cravings for opioids. These medications bind to opioid receptors in the brain, activating them to a lesser extent than full agonists (e.g., heroin or oxycodone), which helps diminish cravings and decrease the urge to use opioids.
Reduces the Risk of Relapse
Medications used in medically assisted treatment have been shown to reduce the risk of relapse and opioid use. By providing relief from withdrawal symptoms and reducing cravings, these medications help individuals stay engaged in treatment, maintain abstinence, and reduce the likelihood of returning to opioid use.
Improves Treatment Retention
Medically assisted drug treatment has been associated with increased retention in treatment programs. By addressing physical symptoms and cravings, these medications make it more likely for individuals to remain engaged in treatment, attend counseling sessions, and participate in other support services. Longer treatment retention is associated with improved outcomes and reduced risk of relapse.
Reduces Mortality and Overdose Risk
Medications used in medically assisted treatment have been shown to significantly reduce the risk of overdose and mortality associated with opioid use disorder. Studies have demonstrated that individuals receiving methadone or buprenorphine have lower rates of fatal overdoses compared to those not receiving medication-assisted treatment.
Comprehensive Approach
Assisted drug treatment is often combined with counseling, behavioral therapies, and support services to provide a comprehensive approach to recovery. This combination addresses both the physical and psychological aspects of addiction, helping individuals develop coping skills, improve interpersonal relationships, and make positive lifestyle changes that support long-term recovery.
It’s important to note that the effectiveness of medically assisted drug treatment can vary depending on individual factors, treatment adherence, and the availability of comprehensive support services. The choice of medication and treatment approach should be made in consultation with a healthcare provider specializing in addiction medicine to ensure an individualized and effective treatment plan.
Buprenorphine
Buprenorphine is a medication used in the treatment of opioid addiction. It belongs to the class of medications known as partial opioid agonists. Buprenorphine has several unique properties that make it effective in managing opioid dependence.
Here’s how buprenorphine is used:
Induction Phase: Buprenorphine treatment typically starts with an induction phase. During this phase, individuals need to be in a state of mild to moderate opioid withdrawal before taking their first dose of buprenorphine. This is to minimize the risk of precipitating withdrawal symptoms.
Maintenance Phase: Once the induction phase is completed successfully, individuals enter the maintenance phase. Buprenorphine is then taken regularly to manage opioid dependence. It works by binding to the opioid receptors in the brain, alleviating withdrawal symptoms and reducing cravings. Buprenorphine is a partial opioid agonist, meaning it activates the receptors to a lesser extent than full agonists like heroin or oxycodone. This produces a milder opioid effect, reducing the risk of overdose and addiction.
Formulations: Buprenorphine is available in various formulations, including sublingual tablets, sublingual films, and long-acting injectable formulations. The sublingual tablets or films are placed under the tongue and left to dissolve. This route of administration allows for the absorption of buprenorphine directly into the bloodstream. Long-acting injectable formulations, such as Sublocade, provide a sustained release of buprenorphine over an extended period, typically administered monthly by a healthcare provider.
Combination Products: Buprenorphine is often combined with naloxone in a product called Suboxone. Naloxone is an opioid antagonist that blocks the effects of opioids and helps deter misuse. When taken sublingually as directed, the naloxone component has limited bioavailability. However, if Suboxone is misused and injected, the naloxone becomes active and can precipitate withdrawal symptoms.
Office-Based Treatment: Buprenorphine can be prescribed by qualified healthcare providers in office-based settings. This allows for increased access to treatment and flexibility in managing opioid addiction. Qualified providers complete specialized training and receive a waiver to prescribe buprenorphine. They can offer ongoing monitoring, support, and counseling as part of a comprehensive treatment plan.
The use of buprenorphine should be part of a comprehensive treatment plan that includes counseling, psychosocial support, and monitoring. The specific dose and duration of treatment are determined by the individual’s needs and may vary. It is essential to consult with a healthcare provider who specializes in addiction medicine for a thorough assessment and personalized treatment plan.
Naloxone
Naloxone is a medication used to reverse opioid overdoses. It belongs to the class of medications called opioid antagonists. Naloxone works by binding to the opioid receptors in the brain, displacing and reversing the effects of opioids. It rapidly blocks the effects of opioids and can restore normal respiration in individuals experiencing an opioid overdose.
Here’s how naloxone is used:
Emergency Response: Naloxone is typically used in emergency situations when an individual is experiencing an opioid overdose. It is administered to reverse the effects of opioids and restore normal breathing. Naloxone can be given by different routes, including intranasal, intramuscular, or intravenous administration.
Intranasal Administration: Intranasal naloxone is available as a nasal spray and is specifically designed for easy and quick administration. The nasal spray is sprayed into one nostril while the individual is lying on their back. The medication is absorbed through the nasal membranes and quickly enters the bloodstream, reversing the effects of opioids.
Intramuscular or Intravenous Administration: In emergency medical settings or by trained healthcare professionals, naloxone can be administered via injection into a muscle (intramuscular) or directly into a vein (intravenous). These routes allow for rapid delivery of the medication and immediate reversal of opioid overdose symptoms.
Community Distribution Programs: In many countries, including the United States, naloxone is available through community-based distribution programs. These programs aim to increase access to naloxone for individuals at risk of opioid overdose and their family members or friends. Naloxone kits may be distributed with instructions on how to administer the medication effectively.
Harm Reduction Approach: Naloxone is a vital tool in harm reduction strategies. It is used to prevent fatal outcomes of opioid overdoses, providing a temporary window of opportunity to seek further medical assistance. By making naloxone readily available to individuals who use opioids and their support networks, it can save lives and contribute to reducing overdose-related mortality.
It’s important to note that naloxone is not a substitute for emergency medical care. Even after administering naloxone, it is essential to seek immediate medical attention for the individual experiencing an overdose. Naloxone has a relatively short duration of action, and repeated doses or additional medical interventions may be necessary.
Naloxone is an important component of opioid overdose response and harm reduction strategies. Training in recognizing and responding to opioid overdoses, including the proper administration of naloxone, is essential for individuals who may encounter overdose situations. Healthcare providers, first responders, and individuals who use opioids or are in close contact with opioid users can benefit from education and training in naloxone administration.
How can we help?
Insurance plays a crucial role in making addiction treatment more accessible and effective for individuals seeking help. insurance support in addiction treatment improves the accessibility and quality of care, leading to better outcomes for those struggling with substance abuse issues. It’s essential for individuals to review their insurance policies to understand what addiction treatment services are covered and seek assistance from their insurance providers when needed.
This will take you to our patient support page, additional information concerning insurance will be located here.
Accepted Insurances
No prior Authorization Needed:
- IHN (Intercommunity Health Plan)
- OREGON MEDICAID
- OREGON MEDICARE
- PACIFIC SOURCE
- NORIDIAN
- REGENCE BLUE CROSS BLUE SHIELD
- TRILLIUM
- CASCADE HEALTH ALLIANCE
Prio Authorization Needed:
- AETNA
- ALLCARE
- CARE OREGON
- CIGNA
- Health Share of Oregon
- KAISER
- MODA
- PH Tech
- Providence
- UMPQUA HEALTH
- UMR
- UNITED HEALTHCARE
Unsupported Insurance
Unfortunately we are unable to accept this insurance providers
MODA
Yamhill
What can we do to help you?
Call during our operational hours to speak with our personnel, we look forward to helping you find productive methods to complete your treatment!
